Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Pulling in cash fast is possible with the right strategies. Learn effective methods to boost your income quickly.
21,139 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
With oil prices near a year high, IEO’s $0.55 quarterly dividend is set to be tested by producer payouts and market s...
As a new era at the Fed begins, chair kevin warsh yearns for sweeping reforms even as two price shocks complicate the...
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
With market volatility and shifting rates, many investors wonder if they should bond your portfolio. This guide break...
A resurfaced teen photo sparked online backlash for Hudson Williams, highlighting how reputational events can ripple ...
As global tensions persist, defense giants report robust backlogs that signal predictable revenue. Here are three hig...
A high-profile insider purchase is drawing attention as American Assets Trust trades near an 18-month high. Discover ...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
Markets show a three-way dance: oil slides, gold falters, and stocks barely move as Alphabet makes its Dow debut. Her...
Curious about Cerebras stock and its three-year outlook? This guide breaks down growth drivers, risks, and three scen...